Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC B Do Van, F Gouel, A Jonneaux, K Timmerman, P Gelé, M Pétrault, ... Neurobiology of disease 94, 169-178, 2016 | 606 | 2016 |
Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis? C Moreau, V Danel, JC Devedjian, G Grolez, K Timmerman, C Laloux, ... Antioxidants & redox signaling 29 (8), 742-748, 2018 | 108 | 2018 |
Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis D Devos, ZI Cabantchik, C Moreau, V Danel, L Mahoney-Sanchez, ... Journal of Neural Transmission 127, 189-203, 2020 | 87 | 2020 |
Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease ML Chou, JW Wu, F Gouel, A Jonneaux, K Timmerman, TY Renn, ... Biomaterials 142, 77-89, 2017 | 54 | 2017 |
Past and future of neurotrophic growth factors therapies in ALS: from single neurotrophic growth factor to stem cells and human platelet lysates F Gouel, AS Rolland, JC Devedjian, T Burnouf, D Devos Frontiers in neurology 10, 835, 2019 | 51 | 2019 |
The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways F Gouel, B Do Van, ML Chou, A Jonneaux, C Moreau, R Bordet, ... Journal of tissue engineering and regenerative medicine 11 (11), 3236-3240, 2017 | 44 | 2017 |
Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways C Petit, F Gouel, I Dubus, C Heuclin, K Roget, JP Vannier BMC cancer 16, 1-17, 2016 | 41 | 2016 |
Disruption of TCA cycle and glutamate metabolism identified by metabolomics in an in vitro model of amyotrophic lateral sclerosis C Veyrat-Durebex, P Corcia, E Piver, D Devos, A Dangoumau, F Gouel, ... Molecular neurobiology 53, 6910-6924, 2016 | 40 | 2016 |
Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease? C Laloux, F Gouel, C Lachaud, K Timmerman, B Do Van, A Jonneaux, ... Neurobiology of disease 103, 24-31, 2017 | 23 | 2017 |
FAIRPARK-II and FAIRALS-II studygroups. Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis D Devos, ZI Cabantchik, C Moreau, V Danel, L Mahoney-Sanchez, ... J. Neural Transm 127, 189-203, 2020 | 22 | 2020 |
What role for angiogenesis in childhood acute lymphoblastic leukaemia? P Schneider, I Dubus, F Gouel, E Legrand, JP Vannier, M Vasse Advances in hematology 2011 (1), 274628, 2011 | 22 | 2011 |
Rac-1 GTPase controls the capacity of human leukaemic lymphoblasts to migrate on fibronectin in response to SDF-1α (CXCL12) M Freret, F Gouel, C Buquet, E Legrand, JP Vannier, M Vasse, I Dubus Leukemia research 35 (7), 971-973, 2011 | 18 | 2011 |
Whole and fractionated human platelet lysate biomaterials-based biotherapy induces strong neuroprotection in experimental models of amyotrophic lateral sclerosis F Gouel, K Timmerman, P Gosset, C Raoul, M Dutheil, A Jonneaux, ... Biomaterials 280, 121311, 2022 | 11 | 2022 |
Ferroptosis, a recently identified cell death, as a therapeutic target for Parkinson''''s disease H Bouchaoui, L Mahoney-Sanchez, A Jonneaux, F Gouel, M Dutheil, ... | 1 | 2019 |
Importance of local hypoxia on endothelial phenotype for an in vitro approach to bone marrow angiogenesis F Gouel, S Kamanzi, C Corbière, C Buquet, E Legrand, JP Vannier, ... Leukemia Research 36 (9), 1200-1203, 2012 | 1 | 2012 |
Long-term inhibition of lysosomal glucocerebrosidase activity promotes GPX4 stability and inhibits ferroptosis in a Parkinson’s model MA Bonte, F Gouel, A Jonneaux, K Belarbi, D Devos, JC Devedjian | | 2024 |
P07-25 Air pollution-derived ultrafine particles induce ferroptosis in differentiated human dopaminergic neuronal LUHMES cells E Theerens, O Simonin, H Bouchaoui, A Jonneaux, F Gouel, ... Toxicology Letters 368, S129-S130, 2022 | | 2022 |
Pharmacological inhibition of lysosomal glucocerebrosidase activity in experimental cellular models of Parkinson's disease MA Bonte, Y Yan, R Bordet, D Devos, F Gouel, JC Devedjian, K Belarbi FUNDAMENTAL & CLINICAL PHARMACOLOGY 36, 73-73, 2022 | | 2022 |
Ferroptosis, a recently identified cell death, as a therapeutic target for Parkinson's disease H Bouchaoui, LM Sanchez, A Jonneaux, F Gouel, J Devedjian, D DEVOS, ... | | 2021 |
Whole and fractionated human platelet lysate induce neuroprotection in severe amyotrophic lateral sclerosis models F Gouel, K Timmerman, P Gosset, C Raoul, M Dutheil, A Jonneaux, ... | | 2021 |